What is he best known for?
The fields of study he is best known for:
His main research concerns Biochemistry, Peptide sequence, Proteome, Virulence and Cell wall.
His Biochemistry study frequently draws connections between related disciplines such as Molecular biology.
His Peptide sequence research includes elements of Proteomics, Active site, Acid phosphatase, Membrane topology and Vanadate.
His Proteome research is multidisciplinary, incorporating elements of Fusarium oxysporum, Xylem, Botany and Candida albicans.
His Virulence study integrates concerns from other disciplines, such as Effector, Pseudomonas syringae, Microbiology and Homology.
His research investigates the connection between Cell wall and topics such as Saccharomyces cerevisiae that intersect with problems in Mannose, Candida glabrata and Bacterial adhesin.
His most cited work include:
- Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein (433 citations)
- A small, cysteine-rich protein secreted by Fusarium oxysporum during colonization of xylem vessels is required for I-3-mediated resistance in tomato (267 citations)
- Proteomic Analysis of Candida albicans Cell Walls Reveals Covalently Bound Carbohydrate-Active Enzymes and Adhesins (230 citations)
What are the main themes of his work throughout his whole career to date?
Henk L. Dekker focuses on Biochemistry, Cancer research, Microbiology, Molecular biology and Cytochrome c oxidase.
His Cell culture research extends to the thematically linked field of Biochemistry.
His Cancer research research is multidisciplinary, incorporating perspectives in Sunitinib, Cancer, Erlotinib, Epidermal growth factor receptor and Kinase.
The concepts of his Microbiology study are interwoven with issues in Cell wall, Solanaceae and Virulence.
His study looks at the relationship between Cytochrome c oxidase and topics such as Cytochrome, which overlap with Cytochrome c and Cooperative binding.
His work deals with themes such as Fusarium oxysporum, Xylem, Botany and Proteomics, Gene, which intersect with Proteome.
He most often published in these fields:
- Biochemistry (34.12%)
- Cancer research (13.53%)
- Microbiology (11.76%)
What were the highlights of his more recent work (between 2011-2021)?
- Cancer research (13.53%)
- Sunitinib (8.82%)
- Kinase (8.24%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cancer research, Sunitinib, Kinase, Biochemistry and Pharmacology.
His Cancer research study combines topics in areas such as Cancer, Erlotinib, Epidermal growth factor receptor, Cell culture and Lung cancer.
The various areas that he examines in his Sunitinib study include Tyrosine kinase, Dasatinib, Tyrosine-kinase inhibitor and Kinase activity.
His Biochemistry research integrates issues from Bacillus subtilis and Mass spectrometry.
He has included themes like Angiogenesis, Intracellular and In vivo in his Pharmacology study.
His work carried out in the field of Proteome brings together such families of science as Quantitative proteomics, Microbiology, Protein biosynthesis, Gene and Alcohol dehydrogenase.
Between 2011 and 2021, his most popular works were:
- Identification of novel candidate phosphatidic acid-binding proteins involved in the salt-stress response of Arabidopsis thaliana roots. (95 citations)
- Time-series resolution of gradual nitrogen starvation and its impact on photosynthesis in the cyanobacterium Synechocystis PCC 6803. (88 citations)
- H2O2 Production in Species of the Lactobacillus acidophilus Group: a Central Role for a Novel NADH-Dependent Flavin Reductase (83 citations)
In his most recent research, the most cited papers focused on:
Biochemistry, Kinase, Cancer research, Tyrosine kinase and Pharmacology are his primary areas of study.
His study on Biochemistry is mostly dedicated to connecting different topics, such as Bacillus subtilis.
His study in Kinase is interdisciplinary in nature, drawing from both Protein kinase B, Phosphorylation, Cancer cell and Non small cell, Lung cancer.
Henk L. Dekker interconnects Cancer stem cell, Cancer, Transcriptome and Apoptosis in the investigation of issues within Cancer research.
His Tyrosine kinase research focuses on Erlotinib and how it relates to non-small cell lung cancer, PI3K/AKT/mTOR pathway and Immunology.
His work focuses on many connections between Pharmacology and other disciplines, such as Sunitinib, that overlap with his field of interest in In vitro, Angiogenesis and Colorectal cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
